In some settings, endoscopic surgical instruments may be preferred over traditional open surgical devices since a smaller incision may reduce the post-operative recovery time and complications. Consequently, some endoscopic surgical instruments may be suitable for placement of a distal end effector at a desired surgical site through a cannula of a trocar. These distal end effectors may engage tissue in a number of ways to achieve a diagnostic or therapeutic effect (e.g., endocutter, grasper, cutter, stapler, clip applier, access device, drug/gene therapy delivery device, and energy delivery device using ultrasound, RF, laser, etc.). Endoscopic surgical instruments may include a shaft between the end effector and a handle portion, which is manipulated by the clinician. Such a shaft may enable insertion to a desired depth and rotation about the longitudinal axis of the shaft, thereby facilitating positioning of the end effector within the patient. Positioning of an end effector may be further facilitated through inclusion of one or more articulation joints or features, enabling the end effector to be selectively articulated or otherwise deflected relative to the longitudinal axis of the shaft.
Examples of endoscopic surgical instruments include surgical staplers. Some such staplers are operable to clamp down on layers of tissue, cut through the clamped layers of tissue, and drive staples through the layers of tissue to substantially seal the severed layers of tissue together near the severed ends of the tissue layers. Merely exemplary surgical staplers are disclosed in; U.S. Pat. No. 4,805,823, entitled “Pocket Configuration for Internal Organ Staplers,” issued Feb. 21, 1989; U.S. Pat. No. 5,415,334, entitled “Surgical Stapler and Staple Cartridge,” issued May 16, 1995; U.S. Pat. No. 5,465,895, entitled “Surgical Stapler Instrument,” issued Nov. 14, 1995; U.S. Pat. No. 5,597,107, entitled “Surgical Stapler Instrument,” issued Jan. 28, 1997; U.S. Pat. No. 5,632,432, entitled “Surgical Instrument,” issued May 27, 1997; U.S. Pat. No. 5,673,840, entitled “Surgical Instrument,” issued Oct. 7, 1997; U.S. Pat. No. 5,704,534, entitled “Articulation Assembly for Surgical Instruments,” issued Jan. 6, 1998; U.S. Pat. No. 5,814,055, entitled “Surgical Clamping Mechanism,” issued Sep. 29, 1998; U.S. Pat. No. 6,964,363, entitled “Surgical Stapling Instrument having Articulation Joint Support Plates for Supporting a Firing Bar,” issued Nov. 15, 2005; U.S. Pat. No. 6,978,921, entitled “Surgical Stapling Instrument Incorporating an E-Beam Firing Mechanism,” issued Dec. 27, 2005; U.S. Pat. No. 6,988,649, entitled “Surgical Stapling Instrument Having a Spent Cartridge Lockout,” issued Jan. 24, 2006; U.S. Pat. No. 7,000,818, entitled “Surgical Stapling Instrument Having Separate Distinct Closing and Firing Systems,” issued Feb. 21, 2006; U.S. Pat. No. 7,111,769, entitled “Surgical Instrument Incorporating an Articulation Mechanism having Rotation about the Longitudinal Axis,” issued Sep. 26, 2006; U.S. Pat. No. 7,143,923, entitled “Surgical Stapling Instrument Having a Firing Lockout for an Unclosed Anvil,” issued Dec. 5, 2006; U.S. Pat. No. 7,303,108, entitled “Surgical Stapling Instrument Incorporating a Multi-Stroke Firing Mechanism with a Flexible Rack,” issued Dec. 4, 2007; U.S. Pat. No. 7,367,485, entitled “Surgical Stapling Instrument Incorporating a Multistroke Firing Mechanism Having a Rotary Transmission,” issued May 6, 2008; U.S. Pat. No. 7,380,695, entitled “Surgical Stapling Instrument Having a Single Lockout Mechanism for Prevention of Firing,” issued Jun. 3, 2008; U.S. Pat. No. 7,380,696, entitled “Articulating Surgical Stapling Instrument Incorporating a Two-Piece E-Beam Firing Mechanism,” issued Jun. 3, 2008; U.S. Pat. No. 7,404,508, entitled “Surgical Stapling and Cutting Device,” issued Jul. 29, 2008; U.S. Pat. No. 7,434,715, entitled “Surgical Stapling Instrument having Multistroke Firing with Opening Lockout,” issued Oct. 14, 2008; U.S. Pat. No. 7,721,930, entitled “Disposable Cartridge with Adhesive for Use with a Stapling Device,” issued May 25, 2010; and U.S. Pat. No. 7,455,208, entitled “Surgical Instrument with Articulating Shaft with Rigid Firing Bar Supports,” issued Nov. 25, 2008. The disclosure of each of the above-cited U.S. Patents is incorporated by reference herein. While the surgical staplers referred to above are described as being used in endoscopic procedures, it should be understood that such surgical staplers may also be used in open procedures and/or other non-endoscopic procedures.
While various kinds of surgical stapling instruments and associated components have been made and used, it is believed that no one prior to the inventor(s) has made or used the invention described in the appended claims.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention, and, together with the general description of the invention given above, and the detailed description of the embodiments given below, serve to explain the principles of the present invention.
The drawings are not intended to be limiting in any way, and it is contemplated that various embodiments of the invention may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention; it being understood, however, that this invention is not limited to the precise arrangements shown.
The following description of certain examples of the invention should not be used to limit the scope of the present invention. Other examples, features, aspects, embodiments, and advantages of the invention will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the invention. As will be realized, the invention is capable of other different and obvious aspects, all without departing from the invention. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
I. Exemplary Surgical Stapler
End effector (12) of the present example includes a lower jaw (16) and a pivotable anvil (18). Handle portion (20) includes pistol grip (24) toward which closure trigger (26) is pivotally drawn by the clinician to cause clamping, or closing, of the anvil (18) toward lower jaw (16) of end effector (12). Such closing of anvil (18) is provided through an outmost closure sleeve (32), which longitudinally translates relative to handle portion (20) in response to pivoting of closure trigger (26) relative to pistol grip (24). A distal closure ring (33) of closure sleeve (32) is indirectly supported by frame (34) of implement portion (22). At articulation mechanism (11), a proximal closure tube (35) of closure sleeve (32) communicates with the distal closure ring (33). Frame (34) is flexibly attached to lower jaw (16) via articulation mechanism (11), enabling articulation in a single plane. Frame (34) also longitudinally slidingly supports a firing drive member (not shown) that extends through shaft (23) and communicates a firing motion from firing trigger (28) to firing bar (14). Firing trigger (28) is farther outboard of closure trigger (26) and is pivotally drawn by the clinician to cause the stapling and severing of clamped tissue in end effector (12), as will be described in greater detail below. Thereafter, release button (30) is depressed to release the tissue from end effector (12).
With end effector (12) closed as depicted in
It should be understood that cutting edge (48) may sever tissue substantially contemporaneously with staples (47) being driven through tissue during each actuation stroke. In the present example, cutting edge (48) just slightly lags behind driving of staples (47), such that a staple (47) is driven through the tissue just before cutting edge (48) passes through the same region of tissue, though it should be understood that this order may be reversed or that cutting edge (48) may be directly synchronized with adjacent staples. While
As noted above, the disclosures of each of those patents are incorporated by reference herein. Additional exemplary modifications that may be provided for instrument (10) will be described in greater detail below. Various suitable ways in which the below teachings may be incorporated into instrument (10) will be apparent to those of ordinary skill in the art. Similarly, various suitable ways in which the below teachings may be combined with various teachings of the patents cited herein will be apparent to those of ordinary skill in the art. It should also be understood that the below teachings are not limited to instrument (10) or devices taught in the patents cited herein. The below teachings may be readily applied to various other kinds of instruments, including instruments that would not be classified as surgical staplers. Various other suitable devices and settings in which the below teachings may be applied will be apparent to those of ordinary skill in the art in view of the teachings herein.
II. Exemplary Firing Bar and Cartridge Assembly to Deposit Adjunct Material
Examples described below include exemplary firing bar and cartridge assemblies operable to deposit adjunct material on tissue while the firing bar severs the tissue and while staples are driven from the cartridge into the tissue. The adjunct material may comprise, for example, adjunct or hemostatic agents such as fibrin or thrombin that assist to coagulate blood and reduce the amount of bleeding at the surgical site. The hemostatic abilities of such adjuncts may also contribute to the use of such adjuncts as adhesives and sealants. The agents may substantially prevent leaks along the stapled tissue site, for example. Such adjuncts or reagents may further include but are not limited to medical fluid or buttress components such as platelet poor plasma (PPP), platelet rich plasma (PRP), starch, chitosan, alginate, fibrin, polysaccharide, cellulose, collagen, bovine collagen, gelatin-resorcin-formalin adhesive, oxidized cellulose, mussel-based adhesive, poly (amino acid), agarose, amylose, hyaluronan, polyhydroxybutyrate (PHB), hyaluronic acid, poly(vinyl pyrrolidone) (PVP), poly(vinyl alcohol) (PVA), polylactide (PLA), polyglycolide (PGA), polycaprolactone (PCL), and their copolymers, VICRYL® (Ethicon, Inc., Somerville, N.J.), MONOCRYL material, PANACRYL (Ethicon, Inc., Somerville, N.J.), and/or any other material suitable to be mixed with biological material and introduced to a wound or defect site, including combinations of materials. For example, the material may be selected from the following materials: epsilon-caprolactone glycolide, bovine pericardium, polylactic acid, polyglycolic acid, polyglactin, polydioxanone, polyglyconate, whey protein, cellulose gum, starch, gelatin, silk, nylon, polypropylene, braided polyester, polybutester, polyethylene, and/or polyetheretherketones. Other suitable compounds, materials, substances, etc., that may be used in a medical fluid or buttress will be apparent to those of ordinary skill in the art in view of the teachings herein.
Suitable adjuncts or reagents may further include but are not limited to medical fluid or buttress components, including but not limited to natural or genetically engineered absorbable polymers or synthetic absorbable polymers, or mixtures thereof. Examples of natural or genetically engineered absorbable polymers are proteins, polysaccharides and combinations thereof. Proteins include, prothrombin, thrombin, fibrinogen, fibrin, fibronectin, heparinase, Factor X/Xa, Factor VII/VIIa, Factor IX/IXa, Factor XI/XIa, Factor XII/XIIa, tissue factor, batroxobin, ancrod, ecarin, von Willebrand Factor, collagen, elastin, albumin, gelatin, platelet surface glycoproteins, vasopressin, vasopressin analogs, epinephrine, selectin, procoagulant venom, plasminogen activator inhibitor, platelet activating agents, synthetic peptides having hemostatic activity, and/or combinations thereof. Polysaccharides include, without limitation, cellulose, alkyl cellulose, e.g. methylcellulose, alkylhydroxyalkyl cellulose, hydroxyalkyl cellulose, cellulose sulfate, salts of carboxymethyl cellulose, carboxymethyl cellulose, carboxyethyl cellulose, chitin, carboxymethyl chitin, hyaluronic acid, salts of hyaluronic acid, alginate, alginic acid, propylene glycol alginate, glycogen, dextran, dextran sulfate, curdlan, pectin, pullulan, xanthan, chondroitin, chondroitin sulfates, carboxymethyl dextran, carboxymethyl chitosan, chitosan, heparin, heparin sulfate, heparan, heparan sulfate, dermatan sulfate, keratan sulfate, carrageenans, chitosan, starch, amylose, amylopectin, poly-N-glucosamine, polymannuronic acid, polyglucuronic acid polyguluronic acid, and derivatives of any of the above. Examples of synthetic absorbable polymers are aliphatic polyester polymers, copolymers, and/or combinations thereof. The aliphatic polyesters are typically synthesized in a ring opening polymerization of monomers including, but not limited to, lactic acid, lactide (including L-, D-, meso and D, L mixtures), glycolic acid, glycolide, ε-caprolactone, p-dioxanone (1,4-dioxan-2-one), and trimethylene carbonate (1,3-dioxan-2-one).
In some versions, a medical fluid may be suspended in a biocompatible carrier to form the material of the adjunct. Suitable carriers may include, for example, a physiological buffer solution, a flowable gel solution, saline, and water. In the case of gel solutions, the tissue repair composition may be in a flowable gel form prior to delivery at the target site, or may form a gel and remain in place after delivery at the target site. Flowable gel solutions may comprise one or more gelling materials with or without added water, saline, or a physiological buffer solution. Suitable gelling materials include biological and synthetic materials. Exemplary gelling materials include proteins, polysaccharides, polynucleotides, and other materials such as alginate, cross-linked alginate, poly(N-isopropylacrylamide), poly(oxyalkylene), copolymers of poly(ethylene oxide)-poly(propylene oxide), poly(vinyl alcohol), polyacrylate, or monostearoyl glycerol co-Succinate/polyethylene glycol (MGSA/PEG) copolymers, and combinations of any of the foregoing.
The material may further be retained in and/or comprise a fibrous pad, a foam, a matrix, a mesh, or another structure, in accordance with the teachings of, by way of example, U.S. Patent App. Pub. No. 2009/0120994, entitled “Surgical Fastening Device with Initiator Impregnation of a Matrix or Buttress to Improve Adhesive Application”, published May 14, 2009, issued as U.S. Pat. No. 7,708,180 on May 4, 2010, the disclosure of which is incorporated by reference herein. The material may comprise, for example, a biocompatible material that is a buttress, a matrix having a plurality of openings therein, an open cell or closed cell foam, and/or a fabric pad. The material may include porosities that induce a wicking feature to drawing adhesive into the material and ensure the openings remain clear of the adhesive, allowing tissue growth through the openings after application to tissue.
Additionally or alternatively, the adjunct material may be comprised of an adhesive such as, but not limited to, polymerizable and/or cross-linkable materials such as a cyanoacrylate adhesive. The adhesive, for example, may be a monomeric (including prepolymeric) adhesive composition, a polymeric adhesive composition, or any other compound that can adhere to tissue. In embodiments, the monomer may be a 1,1-disubstituted ethylene monomer, e.g., an alpha-cyanoacrylate. When cross linked or polymerized, the cyanoacrylate can change from a liquid to a solid. Polymerized adhesives for example, can be formulated to be flexible to rigid and could be spongy. If desired, the adhesive can be a single part or dual part adhesive, and/or can contain additives such as alternate compounds. Polymerization of the adhesive can occur from, but is not limited to, exposure to moisture, heat, and/or adhesion initiators such as those described in U.S. Patent App. Pub. No. 2009/0120994, issued as U.S. Pat. No. 7,708,180 on May 4, 2010, the disclosure of which is incorporated by reference above. Other suitable materials and compositions that may be used will be apparent to those of ordinary skill in the art in view of the teachings herein.
A. Top Notch on Firing Bar Version
Material (114) may be comprised of a hemostatic agent and/or various other materials, as described above. As firing bar (103) moves distally in the direction of arrow (A) through vertical slot (99) defined in upper deck (105) of cartridge (101), firing bar (103) snags and pulls material (114) distally forward while unraveling material (114) from spools (116, 118) as shown in
Tissue is severed by firing bar (103) in a similar manner to how firing bar (14) severs tissue, as described above. Top edge (108) is disposed above top surfaces of spools (116, 118) such that when material (114) is driven forward by firing bar (103), layers of material (114) on either side of firing bar (103) will not come in contact with one another to stick together.
Cartridge (101) includes first and second knives (120, 122) disposed at distal end (124) of slot (99). As firing bar (103) fires distally past knives (120, 122), knives (120, 122) slice through material (114) allowing intermediate portion (112) of material (114) to be removed from notch (110) of firing bar (103). This allows firing bar (103) to return to an original position, shown in
B. Side Notch on Firing Bar Versions
1. Spool Version
2. Surround Version
C. Knife Slots Version
1. Roller Version
Cartridge (119) may include a first version of adjunct applicator (168).
2. Ampoule Version
As another merely illustrative example, cartridge (119) may include a second version of adjunct applicator (176), which is shown in
3. Spring-Biased Gel Block Version
As yet another merely illustrative example, cartridge (119) may include a third version of adjunct applicator (188), which is shown in
It should be understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The following-described teachings, expressions, embodiments, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
Versions of the devices described above may have application in conventional medical treatments and procedures conducted by a medical professional, as well as application in robotic-assisted medical treatments and procedures.
Versions of described above may be designed to be disposed of after a single use, or they can be designed to be used multiple times. Versions may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, some versions of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, some versions of the device may be reassembled for subsequent use either at a reconditioning facility, or by a user immediately prior to a procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
By way of example only, versions described herein may be sterilized before and/or after a procedure. In one sterilization technique, the device is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and device may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the device and in the container. The sterilized device may then be stored in the sterile container for later use. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.
Having shown and described various versions in the present disclosure, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, versions, geometries, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
Number | Name | Date | Kind |
---|---|---|---|
2303131 | Morgan | Nov 1942 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3496940 | Steinman | Feb 1970 | A |
3526228 | Lyng | Sep 1970 | A |
4222383 | Schossow | Sep 1980 | A |
4513746 | Aranyi et al. | Apr 1985 | A |
4549545 | Levy | Oct 1985 | A |
4610250 | Green | Sep 1986 | A |
4693720 | Scharnberg et al. | Sep 1987 | A |
4805823 | Rothfuss | Feb 1989 | A |
5011493 | Belykh et al. | Apr 1991 | A |
5064057 | Iwatsuki et al. | Nov 1991 | A |
5263629 | Trumbull et al. | Nov 1993 | A |
5282829 | Hermes | Feb 1994 | A |
5297324 | Su | Mar 1994 | A |
5327914 | Shlain | Jul 1994 | A |
5366480 | Corriveau et al. | Nov 1994 | A |
5383904 | Totakura et al. | Jan 1995 | A |
5393594 | Koyfman et al. | Feb 1995 | A |
5411193 | Culp | May 1995 | A |
5415334 | Williamson, IV et al. | May 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5496603 | Riedel et al. | Mar 1996 | A |
5503638 | Cooper et al. | Apr 1996 | A |
5542594 | McKean et al. | Aug 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5597107 | Knodel et al. | Jan 1997 | A |
5607590 | Shimizu | Mar 1997 | A |
5607686 | Totakura et al. | Mar 1997 | A |
5632432 | Schulze et al. | May 1997 | A |
5639851 | Bezwada et al. | Jun 1997 | A |
5641566 | Kranzler et al. | Jun 1997 | A |
5644002 | Cooper et al. | Jul 1997 | A |
5673840 | Schulze et al. | Oct 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5704534 | Huitema et al. | Jan 1998 | A |
5711958 | Cohn et al. | Jan 1998 | A |
5733308 | Daugherty et al. | Mar 1998 | A |
5749968 | Melanson et al. | May 1998 | A |
5752965 | Francis et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5766188 | Igaki | Jun 1998 | A |
5769892 | Kingwell | Jun 1998 | A |
5810855 | Rayburn et al. | Sep 1998 | A |
5814055 | Knodel et al. | Sep 1998 | A |
5814057 | Oi et al. | Sep 1998 | A |
5843096 | Igaki et al. | Dec 1998 | A |
5902312 | Frater et al. | May 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6019791 | Wood | Feb 2000 | A |
6031148 | Hayes et al. | Feb 2000 | A |
6099551 | Gabbay | Aug 2000 | A |
6174333 | Kadiyala et al. | Jan 2001 | B1 |
6203564 | Hutton et al. | Mar 2001 | B1 |
6245081 | Bowman et al. | Jun 2001 | B1 |
6273897 | Dalessandro et al. | Aug 2001 | B1 |
6277397 | Shimizu | Aug 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6325810 | Hamilton et al. | Dec 2001 | B1 |
6355699 | Vyakarnam et al. | Mar 2002 | B1 |
6488197 | Whitman | Dec 2002 | B1 |
6495127 | Wallace et al. | Dec 2002 | B1 |
6511748 | Barrows | Jan 2003 | B1 |
6592597 | Grant et al. | Jul 2003 | B2 |
6638285 | Gabbay | Oct 2003 | B2 |
6656193 | Grant et al. | Dec 2003 | B2 |
6704210 | Myers | Mar 2004 | B1 |
6814741 | Bowman et al. | Nov 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6921412 | Black et al. | Jul 2005 | B1 |
6962594 | Thevenet | Nov 2005 | B1 |
6964363 | Wales et al. | Nov 2005 | B2 |
6978921 | Shelton, IV et al. | Dec 2005 | B2 |
6988649 | Shelton, IV et al. | Jan 2006 | B2 |
7000818 | Shelton, IV et al. | Feb 2006 | B2 |
7048755 | Bonutti et al. | May 2006 | B2 |
7084082 | Shimizu | Aug 2006 | B1 |
7111769 | Wales et al. | Sep 2006 | B2 |
7143923 | Shelton, IV et al. | Dec 2006 | B2 |
7147138 | Shelton, IV | Dec 2006 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7211093 | Sauer et al. | May 2007 | B2 |
7268205 | Williams et al. | Sep 2007 | B2 |
7303108 | Shelton, IV | Dec 2007 | B2 |
7335212 | Edoga et al. | Feb 2008 | B2 |
7367485 | Shelton, IV et al. | May 2008 | B2 |
7377928 | Zubik et al. | May 2008 | B2 |
7380695 | Doll et al. | Jun 2008 | B2 |
7380696 | Shelton, IV et al. | Jun 2008 | B2 |
7404508 | Smith et al. | Jul 2008 | B2 |
7431730 | Viola | Oct 2008 | B2 |
7434715 | Shelton, IV et al. | Oct 2008 | B2 |
7434717 | Shelton et al. | Oct 2008 | B2 |
7455208 | Wales et al. | Nov 2008 | B2 |
7517356 | Heinrich | Apr 2009 | B2 |
7559937 | de la Torre et al. | Jul 2009 | B2 |
7607557 | Shelton, IV et al. | Oct 2009 | B2 |
7708180 | Murray et al. | May 2010 | B2 |
7721930 | McKenna et al. | May 2010 | B2 |
7738971 | Swayze et al. | Jun 2010 | B2 |
7845533 | Marczyk et al. | Dec 2010 | B2 |
7950561 | Aranyi | May 2011 | B2 |
8016177 | Bettuchi et al. | Sep 2011 | B2 |
8016178 | Olson et al. | Sep 2011 | B2 |
8070036 | Knodel | Dec 2011 | B1 |
8083119 | Prommersberger | Dec 2011 | B2 |
8157151 | Ingmanson et al. | Apr 2012 | B2 |
8186558 | Sapienza | May 2012 | B2 |
8210414 | Bettuchi et al. | Jul 2012 | B2 |
8215531 | Shelton, IV et al. | Jul 2012 | B2 |
8231043 | Tarinelli et al. | Jul 2012 | B2 |
8474677 | Woodard et al. | Jul 2013 | B2 |
8678263 | Viola | Mar 2014 | B2 |
20020165559 | Grant et al. | Nov 2002 | A1 |
20030120284 | Palacios et al. | Jun 2003 | A1 |
20030183671 | Mooradian et al. | Oct 2003 | A1 |
20040093024 | Lousararian et al. | May 2004 | A1 |
20040167572 | Roth et al. | Aug 2004 | A1 |
20040254608 | Huitema et al. | Dec 2004 | A1 |
20050042250 | Damien et al. | Feb 2005 | A1 |
20050059996 | Bauman et al. | Mar 2005 | A1 |
20050070929 | Dalessandro et al. | Mar 2005 | A1 |
20050101834 | Merade | May 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050145671 | Viola | Jul 2005 | A1 |
20050154403 | Sauer et al. | Jul 2005 | A1 |
20050245965 | Orban, III et al. | Nov 2005 | A1 |
20050249772 | Malaviya et al. | Nov 2005 | A1 |
20050251153 | Sakamoto et al. | Nov 2005 | A1 |
20050283256 | Sommerich et al. | Dec 2005 | A1 |
20050288767 | Kujawski et al. | Dec 2005 | A1 |
20060004388 | Whayne et al. | Jan 2006 | A1 |
20060004407 | Hiles et al. | Jan 2006 | A1 |
20060047312 | Olmo et al. | Mar 2006 | A1 |
20060093655 | Bar et al. | May 2006 | A1 |
20060094318 | Matsuda et al. | May 2006 | A1 |
20060135992 | Bettuchi et al. | Jun 2006 | A1 |
20060173470 | Oray et al. | Aug 2006 | A1 |
20060212069 | Shelton, IV | Sep 2006 | A1 |
20060229672 | Forsberg | Oct 2006 | A1 |
20060265006 | White et al. | Nov 2006 | A1 |
20060265007 | White et al. | Nov 2006 | A1 |
20070016227 | de la Torre et al. | Jan 2007 | A1 |
20070034667 | Holsten et al. | Feb 2007 | A1 |
20070034669 | de la Torre et al. | Feb 2007 | A1 |
20070049953 | Shimoji et al. | Mar 2007 | A2 |
20070060932 | Stack et al. | Mar 2007 | A1 |
20070066981 | Meagher | Mar 2007 | A1 |
20070112360 | De Deyne et al. | May 2007 | A1 |
20070128243 | Serafica et al. | Jun 2007 | A1 |
20070131732 | Holsten et al. | Jun 2007 | A1 |
20070150002 | Szabo et al. | Jun 2007 | A1 |
20070156140 | Baily | Jul 2007 | A1 |
20070190108 | Datta et al. | Aug 2007 | A1 |
20070207180 | Tanihara et al. | Sep 2007 | A1 |
20070213522 | Harris et al. | Sep 2007 | A1 |
20070219571 | Balbierz et al. | Sep 2007 | A1 |
20070225642 | Houser et al. | Sep 2007 | A1 |
20070243227 | Gertner | Oct 2007 | A1 |
20070246505 | Pace-Floridia et al. | Oct 2007 | A1 |
20070286892 | Herzberg et al. | Dec 2007 | A1 |
20080039871 | Wallace et al. | Feb 2008 | A1 |
20080077131 | Yates | Mar 2008 | A1 |
20080078800 | Hess et al. | Apr 2008 | A1 |
20080078801 | Shelton, IV et al. | Apr 2008 | A1 |
20080078802 | Hess et al. | Apr 2008 | A1 |
20080078803 | Shelton, IV et al. | Apr 2008 | A1 |
20080078804 | Shelton, IV et al. | Apr 2008 | A1 |
20080078805 | Omaits et al. | Apr 2008 | A1 |
20080078806 | Omaits et al. | Apr 2008 | A1 |
20080078807 | Hess et al. | Apr 2008 | A1 |
20080081881 | Swetlin et al. | Apr 2008 | A1 |
20080082124 | Hess et al. | Apr 2008 | A1 |
20080082126 | Murray et al. | Apr 2008 | A1 |
20080110958 | McKenna et al. | May 2008 | A1 |
20080110959 | Orban, III et al. | May 2008 | A1 |
20080114381 | Voegele et al. | May 2008 | A1 |
20080114385 | Byrum et al. | May 2008 | A1 |
20080114399 | Bonutti | May 2008 | A1 |
20080125812 | Zubik et al. | May 2008 | A1 |
20080128469 | Dalessandro et al. | Jun 2008 | A1 |
20080140115 | Stopek | Jun 2008 | A1 |
20080200949 | Hiles et al. | Aug 2008 | A1 |
20080314960 | Marczyk et al. | Dec 2008 | A1 |
20090001122 | Prommersberger et al. | Jan 2009 | A1 |
20090076510 | Bell et al. | Mar 2009 | A1 |
20090078739 | Viola | Mar 2009 | A1 |
20090118747 | Bettuchi et al. | May 2009 | A1 |
Number | Date | Country |
---|---|---|
481943 | Feb 1947 | CA |
328 401 | Aug 1989 | EP |
0 667 119 | Aug 1995 | EP |
0 781 564 | Jul 1997 | EP |
0 818 470 | Jan 1998 | EP |
1 098 024 | May 2001 | EP |
1 229 841 | Aug 2002 | EP |
1 494 596 | Jan 2005 | EP |
1 621 141 | Feb 2006 | EP |
1 647 286 | Apr 2006 | EP |
1 759 640 | Mar 2007 | EP |
1 836 974 | Sep 2007 | EP |
2 039 308 | Mar 2009 | EP |
2 789 885 | Aug 2000 | FR |
2 850 281 | Jul 2004 | FR |
222 954 | Oct 1924 | GB |
493 459 | Oct 1938 | GB |
913 218 | Dec 1962 | GB |
107 2740 | Mar 1989 | JP |
3146773 | Jun 1991 | JP |
5076586 | Mar 1993 | JP |
11309151 | Nov 1999 | JP |
WO 9310731 | Jun 1993 | WO |
WO 9838923 | Sep 1998 | WO |
WO 0117446 | Mar 2001 | WO |
WO 0162158 | Aug 2001 | WO |
WO 0209593 | Feb 2002 | WO |
WO 0222184 | Mar 2002 | WO |
WO 03094743 | Nov 2003 | WO |
WO 2004060425 | Jul 2004 | WO |
WO 2006081174 | Aug 2006 | WO |
WO 2006106269 | Oct 2006 | WO |
WO 2007067621 | Jun 2007 | WO |
WO 2008057281 | May 2008 | WO |
Entry |
---|
Abstract for FR2789885. |
Abstract for FR2850281. |
Abstract for JP1072740. |
Abstract for JP11309151. |
Abstract for JP3146773. |
Abstract for JP5076586. |
International Preliminary Report on Patentability dated Mar. 25, 2014 for Application No. PCT/US2012/056066. |
Number | Date | Country | |
---|---|---|---|
20130075451 A1 | Mar 2013 | US |